Last $4.23 USD
Change Today -0.05 / -1.17%
Volume 445.1K
VVUS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 1:48 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Leland F. Wilson

Former Chief Executive Officer and Director, VIVUS Inc.
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 1 different industries.

See Board Relationships
70$4,575,899
As of Fiscal Year 2013

Background*

Mr. Leland F. Wilson serves as a Member of Industry Advisory Board at Valence Life Sciences. He served as the Chief Executive Officer at VIVUS Inc. from November 1991 to July 19, 2013. Previously, Mr. Wilson served as President of VIVUS Inc. from April 1991 to November 3, 2009. He served as an Independent Director at VIVUS Inc. from April 1991 to July 2013. He served as Vice President of Marketing and Corporate Development at Genelabs Technologies, Inc. from 1989 to ...

Read Full Background

Corporate Headquarters*

351 East Evelyn Avenue
Mountain View, California 94041

United States

Phone: 650-934-5200
Fax: --

Board Members Memberships*

1991-2013
Former Chief Executive Officer and Director

Education*

MS
Pennsylvania State University
BS
Pennsylvania State University

Other Affiliations*

Annual Compensation*

Salary$459,355
Total Annual Compensation$459,355

Stock Options*

All Other Compensation$2,453,637
Exercised Options2,095,315
Exercised Options Value$8,990,522
Exercisable Options541,000
Total Value of Options$8,990,522
Total Number of Options2,636,315

Total Compensation*

Total Annual Cash Compensation$2,912,992
Total Short Term Compensation$459,355
Other Long Term Compensation$2,453,637
Total Calculated Compensation$4,575,899
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VVUS:US $4.23 USD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$725.0K
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Zubair Ahmed Managing Director, Executive Director and Member of Whistle Blower Committee
GlaxoSmithKline Consumer Healthcare Limited
97.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIVUS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.